Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Healthy

Interventions

DRUG

Finafloxacin i.v. solution 200 mg

DRUG

Finafloxacin i.v. solution 400 mg

DRUG

Finafloxacin i.v. solution 600 mg

DRUG

Finafloxacin i.v. solution 800 mg

DRUG

Finafloxacin i.v. solution 1000 mg

DRUG

Placebo i.v. solution

Trial Locations (1)

Covance Clinical Research Unit Ltd, Leeds